Immunogenicity of JN.1 and KP.2 COVID-19 mRNA vaccines against emerging SARS-CoV-2 variants. Lasrado N, Rossler A, McConnell I, Molloy K, et al. Vaccine 2025;69:127997.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lasrado N, Rossler A, McConnell I, Molloy K, et al. Immunogenicity of JN.1 and KP.2 COVID-19 mRNA vaccines against emerging SARS-CoV-2 variants. Vaccine 2025;69:127997.
PMID: 41265004